NSEESOP/ESOS/ESPS10 Aug 2026 · 10 Aug 2026, 08:57 pm
ESOP/ESOS/ESPS
Pine Labs Limited · PINELABS
✦ AI SummaryESG
Pine Labs Limited has informed the Exchange regarding the grant of 15,88,789 employee stock options to eligible employees under the Pine Labs Employee Stock Option Plan 2025.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Pine Labs Limited has informed the Exchange regarding Grant of 1588789 Options.
Attachments (1)
📄pdf
Download →
PINELABS_10082026205559_Intimation_-_ESOP_Grant_10082026.pdf
View document text
Date: August 10, 2026
BSE Limited, National Stock Exchange of India Limited,
20th Floor, P.J. Towers, Exchange Plaza, C-1, Block G,
Dalal Street, Bandra Kurla Complex, Bandra (E),
Mumbai - 400001. Mumbai – 400 051
BSE Scrip Code: 544606 NSE Scrip Symbol: PINELABS
Dear Sir/Ma’am,
Subject: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with
Schedule III, we would like to inform that, the Nomination and Remuneration Committee (“NRC”) of Pine Labs
Limited (“the Company”) at its meeting held today, i.e. on August 10, 2026, has approved the grant of 15,88,789
employee stock options to the eligible employees under Pine Labs Employee Stock Option Plan 2025 (“ESOP
Scheme”) of the Company, within the approved limit of 10,20,98,072 stock options by the shareholders.
The required information, in compliance with Para B of Part A of Schedule III to the SEBI Listing Regulations read
with the SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is enclosed as
Annexure A.
The above information will also be available on the website of the Company at https://www.pinelabs.com/investor-
relations.
You are requested to take the same on record.
Thank You.
For Pine Labs Limited
Neerav Mehta
Company Secretary and Compliance Officer
Membership Number: A20949
Encl: a/a
ANNEXURE-A
Details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated
January 30, 2026
Sl. No. Particulars Details
1 Brief details of stock options granted 15,88,789 Options were granted to eligible
employees by Nomination and Remuneration
Committee under Pine Labs Employee Stock
Option Plan 2025.
2 Whether the scheme is in terms of SEBI (Share Yes
Based Employees Benefits and Sweat Equity)
Regulations, 2021
3 Total number of shares covered by these options 15,88,789 (Each stock option is convertible into
one fully paid-up equity share having a face value
of INR 1 each).
4 Pricing formula (Exercise Price) 14,29,976 Options at INR 136.61 per stock option
calculated as Volume Adjusted Weighted Average
Price of last 3 months, discounted by 10%
1,58,813 Options at INR 5.40 per stock option
5 Options vested/Vesting Schedule Options vested - Nil stock options out of 15,88,789
have been vested so far.
Vesting schedule –
15,64,188 Options - vesting period 48 months. 1st
vesting of 25% - on completion of 12 months from
grant date, thereafter monthly vesting.
24,601 Options – vesting period 20 to 36 months.
1st vesting of 25% - on completion of 12 months
from grant date, thereafter monthly vesting.
6 Time within which option may be exercised; The exercise period shall be 5 years from the date
of vesting subject to the terms and conditions of the
Scheme.
7 Options exercised Not Applicable.
8 Money realized by exercise of Options Not Applicable
9 The total number of shares arising as a result of Not Applicable
exercise of Options
10 Options lapsed Not Applicable
11 Variation in terms of Options Not Applicable
12 Brief details of significant terms In addition to terms related to exercise price as per
Sl. No. 4 and vesting schedule as per Sl. No. 5
above, the grantee should be an active employee on
the date of vesting.
Sl. No. Particulars Details
13 Subsequent changes or cancellation or exercise of Not Applicable
such Options
14 Diluted earnings per share pursuant to the issue of Not Applicable
equity shares on exercise of Options